Skip to main content
Clinical Trials/JPRN-UMIN000007569
JPRN-UMIN000007569
Completed
Phase 1

feasibility and efficacy of chemotherapy combined with zoledronic acid : phase I/II trial for adult T-cell leukemia/lymphoma (ZAAT study) - ZAAT study

Saga University, Faculty of Medicine, Devision of Hematology and Oncology0 sites21 target enrollmentMarch 27, 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Saga University, Faculty of Medicine, Devision of Hematology and Oncology
Enrollment
21
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 27, 2012
End Date
October 4, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Saga University, Faculty of Medicine, Devision of Hematology and Oncology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • a)History of glaucome b) Uncontrollable diabetes mellitus or administration of insulin c) Uncontrollable hypertension d) Poor cardiac function e) Active infection requiring systemic therapy f) acute hepatitis, chronic hepatitis, liver cirrhosis g) Synchronous or metachronous maliganacy h) Psychological problem i) active dental disease indicating invasive dental treatment j) Systemic steroid treatment k) History of adminisration of intravenous bisphophonate

Outcomes

Primary Outcomes

Not specified

Similar Trials